Neoplasms: all 9,616 studies

Page 37 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.

• Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular CarcinomaTerminatedNCT00746590Phase 2Results posted
• Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic MalignanciesCompletedNCT00741455Not applicableResults posted
• Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary TreatmentCompletedNCT00734305Phase 1Results posted
• A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid MalignanciesCompletedNCT00732992Phase 1Results posted
• Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine TumorsTerminatedNCT00730483Not applicableResults posted
• A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer PatientsCompletedNCT00728468Phase 1Results posted
• Methadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerTerminatedNCT00726830Not applicableResults posted
• F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer PatientsCompletedNCT00721799Phase 2Results posted
• Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive TractTerminatedNCT00721539Not applicableResults posted
• American Ginseng in Treating Patients With Fatigue Caused by CancerCompletedNCT00719563Phase 3Results posted
• Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other MalignancyCompletedNCT00716976Phase 3Results posted
• Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid TumoursCompletedNCT00716417Phase 1Results posted
• Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell MalignanciesTerminatedNCT00714259Phase 2/3Results posted
• Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct ObstructionCompletedNCT00713427Not applicableResults posted
• Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1TerminatedNCT00708942Phase 2Results posted
• Feasibility of Delphi Screener for Cervical CytologyCompletedNCT00702208Phase 2Results posted
• Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid TumorsCompletedNCT00698841Phase 2Results posted
• Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantCompletedNCT00691015Phase 2Results posted
• Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic MalignanciesTerminatedNCT00689884Not applicableResults posted
• RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in EuropeCompletedNCT00688623Phase 2Results posted
• Study of Denosumab in Subjects With Giant Cell Tumor of BoneCompletedNCT00680992Phase 2Results posted
• LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibCompletedNCT00680901Phase 3Results posted
• INCB018424 in Patients With Advanced Hematologic MalignanciesCompletedNCT00674479Phase 2Results posted
• Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk MalignanciesCompletedNCT00673114Phase 1/2Results posted
• Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic CancerTerminatedNCT00670748Phase 2Results posted
• Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002)CompletedNCT00670488Phase 1Results posted
• Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic NeoplasmsCompletedNCT00666926Phase 1Results posted
• Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainCompletedNCT00666211Phase 3Results posted
• Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients With Myeloid NeoplasmsCompletedNCT00665002Not applicableResults posted
• Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain TumorsTerminatedNCT00659126Phase 2Results posted
• Panitumumab in Children With Solid TumorsCompletedNCT00658658Phase 1Results posted
• A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced MalignanciesCompletedNCT00651664Phase 1Results posted
• A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)CompletedNCT00648648Phase 1Results posted
• CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose DistributionCompletedNCT00643994Not applicableResults posted
• CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy DosimetryCompletedNCT00643617Not applicableResults posted
• Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00643097Phase 2Results posted
• Temozolomide as a Prophylaxis Against Brain Recurrence in Participants With Metastatic Breast Cancer (P05225 AM2)TerminatedNCT00638963Phase 2Results posted
• CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary CarcinomaCompletedNCT00634751Phase 1/2Results posted
• A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED)CompletedNCT00632931Phase 1Results posted
• Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic MelanomaTerminatedNCT00613509Phase 2Results posted
• Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid TumorsCompletedNCT00611468Phase 1Results posted
• Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)CompletedNCT00610129Phase 2Results posted
• GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00607724Phase 1Results posted
• Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged SkinCompletedNCT00601640Phase 2Results posted
• Study Of Sunitinib Plus FOLFOX In Patients With Solid TumorsCompletedNCT00599924Phase 1Results posted
• Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological CancerCompletedNCT00589563Phase 2Results posted
• Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) PatientsTerminatedNCT00585221Phase 2Results posted
• Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated DonorCompletedNCT00582933Phase 2Results posted
• One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation StudyCompletedNCT00580788Early Phase 1Results posted
• Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological MalignanciesCompletedNCT00566696Phase 2Results posted
• Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based RegimenCompletedNCT00561470Phase 3Results posted
• A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid TumorsCompletedNCT00557856Phase 1Results posted
• Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid MalignanciesCompletedNCT00536978Phase 2Results posted
• High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00536601Not applicableResults posted
• Concentration of Ertapenem in Colorectal TissueCompletedNCT00535652Phase 4Results posted
• Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian TumorsCompletedNCT00520013Phase 2Results posted
• Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate CancerCompletedNCT00519285Phase 3Results posted
• Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With CancerCompletedNCT00516503Phase 3Results posted
• Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) TumorsCompletedNCT00515216Phase 2Results posted
• Vandetanib to Treat Children and Adolescents With Medullary Thyroid CancerCompletedNCT00514046Phase 1/2Results posted
• Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantCompletedNCT00513474Phase 1Results posted
• Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or MelanomaTerminatedNCT00512798Phase 1/2Results posted
• Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)TerminatedNCT00506948Phase 2Results posted
• Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell SupportCompletedNCT00506857Phase 1/2Results posted
• Prospective Trial of Vaccine Responses in Childhood Cancer SurvivorsCompletedNCT00505063Phase 2Results posted
• Fatigue in Emergency Center PatientsTerminatedNCT00504985Results posted
• Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial HyperplasiaTerminatedNCT00503581Phase 2Results posted
• A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid TumorsCompletedNCT00500903Phase 1Results posted
• Intermittent Use of Aerosolized Ribavirin for Treatment of RSVCompletedNCT00500578Phase 4Results posted
• Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic MalignanciesCompletedNCT00496860Phase 1Results posted
• Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerCompletedNCT00492089Phase 2Results posted
• Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the FaceCompletedNCT00489086Phase 2Results posted
• Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryTerminatedNCT00482625Phase 2Results posted
• Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative MalignanciesCompletedNCT00481871Phase 1/2Results posted
• Trastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer That Cannot Be Removed by SurgeryTerminatedNCT00478140Phase 2Results posted
• Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell TumorsCompletedNCT00470366Phase 2Results posted
• Study of Cobimetinib in Participants With Solid TumorsCompletedNCT00467779Phase 1Results posted
• Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell TumorsCompletedNCT00467051Phase 2Results posted
• Trial of Dasatinib in Advanced SarcomasCompletedNCT00464620Phase 2Results posted
• Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck CancerCompletedNCT00462735Phase 2Results posted
• Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00453310Phase 2Results posted
• Alemtuzumab and Pentostatin In T-cell NeoplasmsTerminatedNCT00453193Phase 2Results posted
• A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00449033Phase 3Results posted
• Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric AdenocarcinomaCompletedNCT00447330Phase 2Results posted
• Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT00445549Phase 2Results posted
• A Study of MDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesCompletedNCT00441337Phase 1Results posted
• Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver MetastasesCompletedNCT00440310Phase 3Results posted
• Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell TransplantCompletedNCT00439556Phase 2Results posted
• Phase II Study of Sunitinib Malate Following Hepatic Artery EmbolizationCompletedNCT00434109Phase 2Results posted
• Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell TransplantationCompletedNCT00429416Phase 1/2Results posted
• AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsCompletedNCT00427349Phase 2Results posted
• Voraxaze for Delayed Methotrexate ClearanceTerminatedNCT00424645Phase 1/2Results posted
• Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid TumorsCompletedNCT00424632Phase 1Results posted
• Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to CisplatinCompletedNCT00423852Phase 1/2Results posted
• Parenteral Hydration in Advanced Cancer PatientsCompletedNCT00423722Not applicableResults posted
• Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)TerminatedNCT00423150Phase 2Results posted
• XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate CancerCompletedNCT00417079Phase 3Results posted
• A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of MalignanciesCompletedNCT00402714Phase 2Results posted
• Darbepoetin Alfa With or Without Intravenous (IV) IronCompletedNCT00401544Phase 2Results posted
• A Study Of The Safety And Tolerability Of HKI-272 Administered Orally To Japanese Subjects With Advanced Solid TumorsCompletedNCT00397046Phase 1Results posted

← Neoplasms overview